- Home
- VHI vs SIGA Comparison
VHI vs SIGA Comparison
Compare VHI & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHI
- SIGA
- Stock Information
- Founded
- VHI 1932
- SIGA 1995
- Country
- VHI United States
- SIGA United States
- Employees
- VHI N/A
- SIGA N/A
- Industry
- VHI Major Chemicals
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- VHI Industrials
- SIGA Health Care
- Exchange
- VHI Nasdaq
- SIGA Nasdaq
- Market Cap
- VHI 447.6M
- SIGA 422.9M
- IPO Year
- VHI N/A
- SIGA 1997
- Fundamental
- Price
- VHI $17.59
- SIGA $6.69
- Analyst Decision
- VHI Sell
- SIGA
- Analyst Count
- VHI 1
- SIGA 0
- Target Price
- VHI $12.00
- SIGA N/A
- AVG Volume (30 Days)
- VHI 24.7K
- SIGA 355.7K
- Earning Date
- VHI 08-07-2025
- SIGA 07-31-2025
- Dividend Yield
- VHI 1.83%
- SIGA 9.04%
- EPS Growth
- VHI 4465.30
- SIGA N/A
- EPS
- VHI 4.11
- SIGA 0.67
- Revenue
- VHI $2,112,800,000.00
- SIGA $120,330,310.00
- Revenue This Year
- VHI $22.20
- SIGA N/A
- Revenue Next Year
- VHI $7.66
- SIGA $95.31
- P/E Ratio
- VHI $4.32
- SIGA $9.89
- Revenue Growth
- VHI 7.82
- SIGA N/A
- 52 Week Low
- VHI $14.10
- SIGA $4.95
- 52 Week High
- VHI $41.75
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- VHI 54.59
- SIGA 55.85
- Support Level
- VHI $17.53
- SIGA $6.69
- Resistance Level
- VHI $18.38
- SIGA $6.85
- Average True Range (ATR)
- VHI 0.79
- SIGA 0.19
- MACD
- VHI -0.07
- SIGA -0.02
- Stochastic Oscillator
- VHI 38.05
- SIGA 49.32
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.